Pilot Funding

University of Rochester Core Center for Musculoskeletal Biology and Medicine

The University of Rochester Core Center for Musculoskeletal Biology and Medicine (URCCMBM) is requesting applications from New Investigators for funding of pilot projects.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) was awarded a Research Core Center (P30) in musculoskeletal biology and medicine to the University of Rochester. This URCCMBM provides shared facilities and services to groups of established, currently funded investigators addressing scientific problems in musculoskeletal biology and medicine, in order to improve efficiency, accelerate the pace of research, and ensure greater productivity. It also awards pilot project grants to Physician-Scientists, Research Assistant Professors and Assistant Professors who have not received NIH R01 or equivalent grant funding as Principal Investigator, for research aimed at improving the diagnosis, treatment and prevention of diseases and injuries of the musculoskeletal system and its component tissues. The pilot grant program is intended to provide seed funding to facilitate new research where multidisciplinary research and translational and clinical based research are encouraged among investigators to move toward a common goal of new discoveries along the continuum to humans and the community.

All principal investigators of proposals must be faculty at the University of Rochester.

Proposal Submission:
A face page application form and investigator’s proposal (in a modified NIH format with a 6 page maximum, 11-point font minimum) and budget form with a budget justification should be submitted electronically by email to Bonnie_Lipari@urmc.rochester.edu (phone: 585-273-5635).

Deadlines:
Proposals must be received by February 20, 2015.
Applicants will be notified of awards by May 1, 2015, which will be initiated immediately. The funding must be expended by June 30, 2016.

Note:
All animal and human subject protocols must be approved prior to the start date. No funds will be released until these approvals have been documented.

Please see the full announcement for more details